Food Standards are an important component of FDA’s oversight, ensuring honesty and fairness to the consumer through requirements that provide for the basic nature of a standardized food to be uniform in terms of its characteristics as well as the ingredients that it must or may contain, (i.e., mandatory and optional ingredients. But what happens when a newly developed food or production method warrants consideration of a product category outside of the standard? Petitioning to amend a food standard or to create a new one, is a lengthy and complicated process; however, a temporary solution may be available through a specialized category called a Temporary Marketing Permit(TMP’s). With TMP’s companies with novel standardized food innovations may apply to market test a food product that deviates from the standard of identity for that particular food, providing FDA with data needed to consider a future petition to amend the standard.
About the Presenter
April Kates was most recently a supervisory consumer safety officer at FDA. Prior to that position, she served with USDA’s Food Safety and Inspection Service Federal-State Audit Branch, also as a supervisory consumer safety officer. Previously, she served as manager of regulatory compliance at McCormick Spice Company, as a food regulatory specialist at American Ingredients Company (now Corbion), as a program analyst at FSIS, and as a food technologist at FDA.
Have you ever wondered why your foreign suppliers: API, intermediates, food ingredients, etc. are suddenly in trouble with regulatory authorities? Did they just go astray or is your auditing program not performing as designed? Actually, there are several things at play. EAS Independent Consultant, Peter Saxon, will shed some light on reasons FDA inspections can “go south” as well as provide insight on how disappointing results can be managed. Saxon has personally attended 90 FDA inspections of foreign facilities and another 15 inspections by other regulatory agencies (TGA, WHO, EDQM). His insights will provide an opportunity for companies to consider improvements to their internal audit structure to help minimize regulatory risks.
About the Presenter
Peter Saxon has extensive experience in assisting pharmaceutical companies to prepare for FDA inspections of API and finished dosage plants for the U.S. market. He brings 45 years of experience in technical operations, materials management, and business development background in the pharmaceutical industry. His expertise includes pre-inspection audits, Drug Master File (DMF) preparation, equipment, cleaning, computer and process validations as well as QA training. A consultant since 1993, he has assisted major US pharmaceutical companies through FDA consent decrees and guided foreign API and finished dosage manufacturers through FDA inspections. Prior to consulting Saxon served in management roles with Ciba-Geigy Corporation, including stints in Cairo, Egypt, and Basel, Switzerland. Mr. Saxon holds an MBA from Rutgers University, and a BS in chemical engineering from Manhattan College, Riverdale, NY. He is fluent in German and has a working knowledge of Spanish, French, Arabic, and Chinese
Just wanted to say thank you for the information shared at the Dietary Supplement GMP training last week. I’ve been to many trainings/seminars over the years, many of which I left thinking “WOW…I’m never going to use what I just learned.” I’m pleased to say that after leaving this training, I felt confident that I’d be immediately using at least 90% of the information that I learned. There are several follow-ups that I have planned here, some of which were points that I’m not sure we were aware of, and others that will only strengthen some of our current programs. The training was informative and very well delivered. The Q&A allowed throughout was also informative, yet never veered too far off course. As a previous trainer, I understand how important good interaction can be, but I also understand how quickly a conversation can go off on a tangent. You had a great mix of letting things happen, yet kept it corralled. Great job!
Thanks for delivering a jam-packed learning experience. It was so well done and very important work. I’m feeling ready to roll up my sleeves!
I consider myself a seasoned professional in regulatory compliance for the food/supplement industry. The instructors were very personal and information was presented with lots of practical experiences and details. Powerful take aways! Never too experienced to learn a whole lot more!
I wanted to write a quick note and say that I thoroughly enjoyed the training class. It was extremely thorough, packed with useful information, and was presented very well. Thank you very much for sharing both of your experiences as well; they definitely added significant value because of the real-world applications for the information. I was really excited to share it with my management team!
You [Bob Fish] and the other instructors did a great job with the course! I learned a lot. I feel like a new person, and am now more equipped to audit my contract manufacturers against the standard. Thanks for answering all of my questions and giving your insight on industry findings.
The program was extremely comprehensive. The course materials were structured and detailed. It broke down 21 CFR Part 111 into very easy to comprehend sections that allowed me to simultaneously create a list of immediate actions to apply at our facility to help us become even more GMP compliant! The course helped me to understand how to tie up a lot of previously confusing loose ends. Thank you to all the instructors and to EAS for providing the course!
I am very impressed with the quality of this presentation and the presenters. I am new to cGMP and this has been a most valuable overview.
Tara Lin Couch, Ph.D.
Senior Director, Dietary Supplement and Tobacco Services
As states begin to regulate legalized cannabis, the concern of how Good Manufacturing Practices (GMPs) apply to this unique industry cannot be understated. While regulations vary from state to state the quality systems under which cannabis products are grown and manufactured have similarities that can begin to pave the way for putting practices and procedures in place to meet compliance expectations, including those of testing and quality control of in-process materials, finished batches and packaged/labeled products. The time is right for the Cannabis industry to begin assessing your manufacturing processes and implementing sound and effective quality systems in order to help you begin to prepare for GMP regulations. Stay ahead of the curve, standardize your product quality and be a leader in your industry.
About the instructor
Tara Lin Couch, PhD
Senior Director, Dietary Supplement and Tobacco Services
Dr. Tara Lin Couch is a Ph.D. Analytical / Organic Chemist with exceptional analytical abilities and over 25 years of diverse laboratory and regulatory experience in academic, field, contract, and manufacturing environments. She is a sought-after expert on issues pertaining to Quality Control in pharmaceutical, dietary supplement and tobacco manufacturing facilities including the establishment of specifications and the development of well-organized, sophisticated laboratories. As a Senior Director for EAS Consulting Group, Dr. Couch has assisted numerous companies with the development, improvement, and implementation of strong Quality Systems that are scientifically sound, efficient, practical, and compliant with all FDA regulations. She also performs mock FDA inspections, gap-analyses, and contractor facility audits. In addition, Dr. Couch provides GMP and laboratory training via seminar, webinar, and on-site presentations.